The ACR has developed two new clinical guidance documents for pediatric patients in the context of the COVID-19 pandemic.
More Evidence Links Pediatric Inflammatory Multisystem Syndrome to SARS-CoV-2
NEW YORK (Reuters Health)—Two new reports in JAMA strengthen the link between SARS-CoV-2 infection and pediatric inflammatory multisystem syndrome (PIMS). Pediatricians from several communities have reported children who developed fever and multisystem inflammation during the COVID-19 pandemic. Some children were critically ill and some had characteristics similar to Kawasaki disease or Kawasaki disease shock syndrome….
After Hip Fracture, Earlier Osteoporosis Drug Initiation Tied to Lower Subsequent Fracture Risk
(Reuters Health)—Patients hospitalized for a hip fracture are less likely to experience a subsequent fracture-related hospitalization if they start anti-osteoporosis medication sooner, a Taiwanese study suggests.1 Researchers examined data on 77,930 patients aged 50 years and older hospitalized for hip fractures, including 9,986 people prescribed anti-osteoporosis medications within one year of the index fracture. Compared…
People with Rheumatic Diseases Should Pay Extra Attention to Self-Care During COVID-19
NEW YORK (Reuters Health)—People with rheumatic diseases should continue their medicines, monitor their health and avoid stress when possible during the current coronavirus pandemic, according to a group of rheumatologists in South Korea.1 Because rheumatic diseases are linked with chronic inflammation and abnormal immune functions, patients may be at a greater risk for COVID-19 infection,…
An Important Message from the ACR on the Death of George Floyd
The American College of Rheumatology is deeply troubled by the recent events surrounding the death of George Floyd. This tragedy is the latest in a long history of senseless killings of people of color. We recognize that racial inequality is an invisible undercurrent impacting the lives of many of our members and patients, and we…
Novel Cathepsin K Inhibitor Promising for OA
Research into the disease-modifying effects of the novel cathepsin K inhibitor MIV-711 suggests it may be effective as a knee OA treatment. In OA patients using the treatment, the study documented statistically significant reductions in bone and cartilage progression…
Serological Antibody Tests in COVID-19: Test Reliability and Utility
Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…
Advocacy During a Pandemic: An Update from the Government Affairs Committee
Although the COVID-19 outbreak has shifted the focus and approach of advocacy efforts, ACR staff and the Government Affairs Committee continue to work on behalf of rheumatology providers and patients.
ACR Continues to Advocate Against Payer Mandates on Specialty Pharmacy Acquisition of In-Office Treatments
Despite efforts by the ACR and other organizations, Blue Cross Blue Shield of Tennessee has indicated that it will move forward with implementation of its specialty pharmacy acquisition mandate on July 1, 2020.
Influential Lancet Article on HCQ Retracted
NEW YORK, June 4 (Reuters)—Three of the authors of an influential article that found hydroxychloroquine (HCQ) increased the risk of death in COVID-19 patients retracted the study, citing concerns about the quality of the data behind it. The anti-malarial drug has been controversial in part due to support from U.S. President Donald Trump, as well…
- « Previous Page
- 1
- …
- 84
- 85
- 86
- 87
- 88
- …
- 317
- Next Page »